{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:15:20Z","timestamp":1788491720148,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"38","license":[{"start":{"date-parts":[[2012,1,16]],"date-time":"2012-01-16T00:00:00Z","timestamp":1326672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,1,16]],"date-time":"2012-01-16T00:00:00Z","timestamp":1326672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2012,9,20]]},"DOI":"10.1038\/onc.2011.578","type":"journal-article","created":{"date-parts":[[2012,1,16]],"date-time":"2012-01-16T17:21:42Z","timestamp":1326734502000},"page":"4221-4232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma"],"prefix":"10.1038","volume":"31","author":[{"given":"S I","family":"Rothschild","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M P","family":"Tschan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E A","family":"Federzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Jaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M F","family":"Fey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Gugger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Gautschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,16]]},"reference":[{"key":"BFonc2011578_CR1","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nprot.2006.466","volume":"2","author":"A Albini","year":"2007","unstructured":"Albini A, Benelli R . (2007). The chemoinvasion assay: a method to assess tumor and endothelial cell invasion and its modulation. Nat Protoc 2: 504\u2013511.","journal-title":"Nat Protoc"},{"key":"BFonc2011578_CR2","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1158\/1078-0432.CCR-09-2638","volume":"16","author":"JA Bishop","year":"2010","unstructured":"Bishop JA, Benjamin H, Cholakh H, Chajut A, Clark DP, Westra WH . (2010). Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach. Clin Cancer Res 16: 610\u2013619.","journal-title":"Clin Cancer Res"},{"key":"BFonc2011578_CR3","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/nm0705-712","volume":"11","author":"C Caldas","year":"2005","unstructured":"Caldas C, Brenton JD . (2005). Sizing up miRNAs as cancer genes. Nat Med 11: 712\u2013714.","journal-title":"Nat Med"},{"key":"BFonc2011578_CR4","doi-asserted-by":"publisher","first-page":"7390","DOI":"10.1158\/0008-5472.CAN-06-0800","volume":"66","author":"GA Calin","year":"2006","unstructured":"Calin GA, Croce CM . (2006). MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 66: 7390\u20137394.","journal-title":"Cancer Res"},{"key":"BFonc2011578_CR5","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1056\/NEJMoa050995","volume":"353","author":"GA Calin","year":"2005","unstructured":"Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE et al. (2005). A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353: 1793\u20131801.","journal-title":"N Engl J Med"},{"key":"BFonc2011578_CR6","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1073\/pnas.0307323101","volume":"101","author":"GA Calin","year":"2004","unstructured":"Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S et al. (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 101: 2999\u20133004.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFonc2011578_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/ng.2007.30","volume":"40","author":"TC Chang","year":"2008","unstructured":"Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM et al. (2008a). Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 40: 43\u201350.","journal-title":"Nat Genet"},{"key":"BFonc2011578_CR8","doi-asserted-by":"publisher","first-page":"6365","DOI":"10.1038\/onc.2008.250","volume":"27","author":"YM Chang","year":"2008","unstructured":"Chang YM, Bai L, Liu S, Yang JC, Kung HJ, Evans CP . (2008b). Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530. Oncogene 27: 6365\u20136375.","journal-title":"Oncogene"},{"key":"BFonc2011578_CR9","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/nrg2634","volume":"10","author":"CM Croce","year":"2009","unstructured":"Croce CM . (2009). Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10: 704\u2013714.","journal-title":"Nat Rev Genet"},{"key":"BFonc2011578_CR10","doi-asserted-by":"publisher","first-page":"15805","DOI":"10.1073\/pnas.0707628104","volume":"104","author":"M Fabbri","year":"2007","unstructured":"Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E et al. (2007). MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A 104: 15805\u201315810.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFonc2011578_CR11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.molmed.2004.06.008","volume":"10","author":"S Fong","year":"2004","unstructured":"Fong S, Debs RJ, Desprez PY . (2004). Id genes and proteins as promising targets in cancer therapy. Trends Mol Med 10: 387\u2013392.","journal-title":"Trends Mol Med"},{"key":"BFonc2011578_CR12","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1073\/pnas.0800135105","volume":"105","author":"R Garzon","year":"2008","unstructured":"Garzon R, Garofalo M, Martelli MP, Briesewitz R, Wang L, Fernandez-Cymering C et al. (2008). Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci U S A 105: 3945\u20133950.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFonc2011578_CR13","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1158\/0008-5472.CAN-07-6403","volume":"68","author":"O Gautschi","year":"2008","unstructured":"Gautschi O, Tepper CG, Purnell PR, Izumiya Y, Evans CP, Green TP et al. (2008). Regulation of Id1 expression by SRC: implications for targeting of the bone morphogenetic protein pathway in cancer. Cancer Res 68: 2250\u20132258.","journal-title":"Cancer Res"},{"key":"BFonc2011578_CR14","doi-asserted-by":"publisher","first-page":"265","DOI":"10.2144\/000113083","volume":"46","author":"T Geb\u00e4ck","year":"2009","unstructured":"Geb\u00e4ck T, Schulz MM, Koumoutsakos P, Detmar M . (2009). TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays. Biotechniques 46: 265\u2013274.","journal-title":"Biotechniques"},{"key":"BFonc2011578_CR15","doi-asserted-by":"publisher","first-page":"D140","DOI":"10.1093\/nar\/gkj112","volume":"34","author":"S Griffiths-Jones","year":"2006","unstructured":"Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ . (2006). miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140\u2013D144.","journal-title":"Nucleic Acids Res"},{"key":"BFonc2011578_CR16","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nature09267","volume":"466","author":"H Guo","year":"2010","unstructured":"Guo H, Ingolia NT, Weissman JS, Bartel DP . (2010). Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466: 835\u2013840.","journal-title":"Nature"},{"key":"BFonc2011578_CR17","doi-asserted-by":"publisher","first-page":"7065","DOI":"10.1158\/0008-5472.CAN-05-1783","volume":"65","author":"MV Iorio","year":"2005","unstructured":"Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S et al. (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065\u20137070.","journal-title":"Cancer Res"},{"key":"BFonc2011578_CR18","doi-asserted-by":"publisher","first-page":"e363","DOI":"10.1371\/journal.pbio.0020363","volume":"2","author":"B John","year":"2004","unstructured":"John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS . (2004). Human MicroRNA targets. PLoS Biol 2: e363.","journal-title":"PLoS Biol"},{"key":"BFonc2011578_CR19","doi-asserted-by":"publisher","first-page":"4609","DOI":"10.1200\/JCO.2010.30.5474","volume":"28","author":"FM Johnson","year":"2010","unstructured":"Johnson FM, Bekele BN, Feng L, Wistuba I, Tang XM, Tran HT et al. (2010). Phase II study of dasatinib in patients with advanced non-small-cell lung cancer. J Clin Oncol 28: 4609\u20134615.","journal-title":"J Clin Oncol"},{"key":"BFonc2011578_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1073\/pnas.012283399","volume":"99","author":"MD Kaeser","year":"2002","unstructured":"Kaeser MD, Iggo RD . (2002). Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo. Proc Natl Acad Sci U S A 99: 95\u2013100.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFonc2011578_CR21","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/ng1536","volume":"37","author":"A Krek","year":"2005","unstructured":"Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ et al. (2005). Combinatorial microRNA target predictions. Nat Genet 37: 495\u2013500.","journal-title":"Nat Genet"},{"key":"BFonc2011578_CR22","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1093\/carcin\/bgg100","volume":"24","author":"EM Langenfeld","year":"2003","unstructured":"Langenfeld EM, Calvano SE, Abou-Nukta F, Lowry SF, Amenta P, Langenfeld J . (2003). The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells. Carcinogenesis 24: 1445\u20131454.","journal-title":"Carcinogenesis"},{"key":"BFonc2011578_CR23","doi-asserted-by":"publisher","first-page":"8326","DOI":"10.1038\/sj.onc.1205093","volume":"20","author":"A Lasorella","year":"2001","unstructured":"Lasorella A, Uo T, Iavarone A . (2001). Id proteins at the cross-road of development and cancer. Oncogene 20: 8326\u20138333.","journal-title":"Oncogene"},{"key":"BFonc2011578_CR24","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1200\/JCO.2008.19.4134","volume":"27","author":"D Lebanony","year":"2009","unstructured":"Lebanony D, Benjamin H, Gilad S, Ezagouri M, Dov A, Ashkenazi K et al. (2009). Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J Clin Oncol 27: 2030\u20132037.","journal-title":"J Clin Oncol"},{"key":"BFonc2011578_CR25","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1200\/JCO.2005.04.044","volume":"23","author":"NB Leighl","year":"2005","unstructured":"Leighl NB, Paz-Ares L, Douillard JY, Peschel C, Arnold A, Depierre A et al. (2005). Randomized phase III study of matrix metalloproteinase inhibitor BMS-275291 in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR 18. J Clin Oncol 23: 2831\u20132839.","journal-title":"J Clin Oncol"},{"key":"BFonc2011578_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","volume":"120","author":"BP Lewis","year":"2005","unstructured":"Lewis BP, Burge CB, Bartel DP . (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15\u201320.","journal-title":"Cell"},{"key":"BFonc2011578_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD . (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402\u2013408.","journal-title":"Methods"},{"key":"BFonc2011578_CR28","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/44334","volume":"401","author":"D Lyden","year":"1999","unstructured":"Lyden D, Young AZ, Zagzag D, Yan W, Gerald W, O'Reilly R et al. (1999). Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401: 670\u2013677.","journal-title":"Nature"},{"key":"BFonc2011578_CR29","first-page":"716","volume":"109","author":"KS McCarty Jr","year":"1985","unstructured":"McCarty Jr KS, Miller LS, Cox EB, Konrath J, McCarty Sr KS . (1985). Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 109: 716\u2013721.","journal-title":"Arch Pathol Lab Med"},{"key":"BFonc2011578_CR30","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ceb.2006.08.011","volume":"18","author":"SK Mitra","year":"2006","unstructured":"Mitra SK, Schlaepfer DD . (2006). Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol 18: 516\u2013523.","journal-title":"Curr Opin Cell Biol"},{"key":"BFonc2011578_CR31","doi-asserted-by":"publisher","first-page":"6133","DOI":"10.1038\/sj.onc.1210436","volume":"26","author":"JL Mott","year":"2007","unstructured":"Mott JL, Kobayashi S, Bronk SF, Gores GJ . (2007). mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 26: 6133\u20136140.","journal-title":"Oncogene"},{"key":"BFonc2011578_CR32","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/jcb.22630","volume":"110","author":"JL Mott","year":"2010","unstructured":"Mott JL, Kurita S, Cazanave SC, Bronk SF, Werneburg NW, Fernandez-Zapico ME . (2010). Transcriptional suppression of mir-29b-1\/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB. J Cell Biochem 110: 1155\u20131164.","journal-title":"J Cell Biochem"},{"key":"BFonc2011578_CR33","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.1016\/j.ejca.2009.09.014","volume":"45","author":"MK Muniyappa","year":"2009","unstructured":"Muniyappa MK, Dowling P, Henry M, Meleady P, Doolan P, Gammell P et al. (2009). MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell lines. Eur J Cancer 45: 3104\u20133118.","journal-title":"Eur J Cancer"},{"key":"BFonc2011578_CR34","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1755-8794-1-9","volume":"1","author":"A Oberli","year":"2008","unstructured":"Oberli A, Popovici V, Delorenzi M, Baltzer A, Antonov J, Matthey S et al. (2008). Expression profiling with RNA from formalin-fixed, paraffin-embedded material. BMC Med Genomics 1: 9.","journal-title":"BMC Med Genomics"},{"key":"BFonc2011578_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1158\/0008-5472.CAN-09-3153","volume":"70","author":"SK Patnaik","year":"2010","unstructured":"Patnaik SK, Kannisto E, Knudsen S, Yendamuri S . (2010). Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Cancer Res 70: 36\u201345.","journal-title":"Cancer Res"},{"key":"BFonc2011578_CR36","doi-asserted-by":"publisher","first-page":"11590","DOI":"10.1158\/0008-5472.CAN-06-3613","volume":"66","author":"Y Pekarsky","year":"2006","unstructured":"Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, Efanov A, Maximov V et al. (2006). Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 66: 11590\u201311593.","journal-title":"Cancer Res"},{"key":"BFonc2011578_CR37","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3816\/CLC.2010.n.030","volume":"11","author":"SI Rothschild","year":"2010","unstructured":"Rothschild SI, Gautschi O, Haura EB, Johnson FM . (2010). Src inhibitors in lung cancer: current status and future directions. Clin Lung Cancer 11: 238\u2013242.","journal-title":"Clin Lung Cancer"},{"key":"BFonc2011578_CR38","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.lungcan.2010.06.018","volume":"71","author":"SI Rothschild","year":"2011","unstructured":"Rothschild SI, Kappeler A, Ratschiller D, Betticher DC, Tschan MP, Gugger M et al. (2011). The stem cell gene \u201cinhibitor of differentiation 1\u201d (ID1) is frequently expressed in non-small cell lung cancer. Lung Cancer 71: 306\u2013311.","journal-title":"Lung Cancer"},{"key":"BFonc2011578_CR39","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1158\/1078-0432.CCR-05-2692","volume":"12","author":"JM Summy","year":"2006","unstructured":"Summy JM, Gallick GE . (2006). Treatment for advanced tumors: SRC reclaims center stage. Clin Cancer Res 12: 1398\u20131401.","journal-title":"Clin Cancer Res"},{"key":"BFonc2011578_CR40","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1093\/carcin\/bgp251","volume":"30","author":"X Sun","year":"2009","unstructured":"Sun X, Li C, Zhuang C, Gilmore WC, Cobos E, Tao Y et al. (2009). Abl interactor 1 regulates Src-Id1-matrix metalloproteinase 9 axis and is required for invadopodia formation, extracellular matrix degradation and tumor growth of human breast cancer cells. Carcinogenesis 30: 2109\u20132116.","journal-title":"Carcinogenesis"},{"key":"BFonc2011578_CR41","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/sj.onc.1208188","volume":"24","author":"A Swarbrick","year":"2005","unstructured":"Swarbrick A, Akerfeldt MC, Lee CS, Sergio CM, Caldon CE, Hunter LJ et al. (2005). Regulation of cyclin expression and cell cycle progression in breast epithelial cells by the helix-loop-helix protein Id1. Oncogene 24: 381\u2013389.","journal-title":"Oncogene"},{"key":"BFonc2011578_CR42","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1158\/0008-5472.CAN-04-0637","volume":"64","author":"J Takamizawa","year":"2004","unstructured":"Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H et al. (2004). Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64: 3753\u20133756.","journal-title":"Cancer Res"},{"key":"BFonc2011578_CR43","doi-asserted-by":"publisher","first-page":"42750","DOI":"10.1074\/jbc.M307067200","volume":"278","author":"MP Tschan","year":"2003","unstructured":"Tschan MP, Fischer KM, Fung VS, Pirnia F, Borner MM, Fey MF et al. (2003). Alternative splicing of the human cyclin D-binding Myb-like protein (hDMP1) yields a truncated protein isoform that alters macrophage differentiation patterns. J Biol Chem 278: 42750\u201342760.","journal-title":"J Biol Chem"},{"key":"BFonc2011578_CR44","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1101\/gad.1399806","volume":"20","author":"MA Valencia-Sanchez","year":"2006","unstructured":"Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R . (2006). Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 20: 515\u2013524.","journal-title":"Genes Dev"},{"key":"BFonc2011578_CR45","doi-asserted-by":"publisher","first-page":"8288","DOI":"10.1158\/0008-5472.CAN-10-1348","volume":"70","author":"J Voortman","year":"2010","unstructured":"Voortman J, Goto A, Mendiboure J, Sohn JJ, Schetter AJ, Saito M et al. (2010). MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma. Cancer Res 70: 8288\u20138298.","journal-title":"Cancer Res"},{"key":"BFonc2011578_CR46","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1097\/JTO.0b013e3181a99c77","volume":"4","author":"X Wu","year":"2009","unstructured":"Wu X, Piper-Hunter MG, Crawford M, Nuovo GJ, Marsh CB, Otterson GA et al. (2009). MicroRNAs in the pathogenesis of Lung Cancer. J Thorac Oncol 4: 1028\u20131034.","journal-title":"J Thorac Oncol"},{"key":"BFonc2011578_CR47","doi-asserted-by":"publisher","first-page":"6275","DOI":"10.1158\/0008-5472.CAN-08-4517","volume":"69","author":"H Xu","year":"2009","unstructured":"Xu H, Cheung IY, Guo HF, Cheung NK . (2009). MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors. Cancer Res 69: 6275\u20136281.","journal-title":"Cancer Res"},{"key":"BFonc2011578_CR48","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ccr.2006.01.025","volume":"9","author":"N Yanaihara","year":"2006","unstructured":"Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M et al. (2006). Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189\u2013198.","journal-title":"Cancer Cell"},{"key":"BFonc2011578_CR49","doi-asserted-by":"publisher","first-page":"8290","DOI":"10.1038\/sj.onc.1205090","volume":"20","author":"Y Yokota","year":"2001","unstructured":"Yokota Y . (2001). Id and development. Oncogene 20: 8290\u20138298.","journal-title":"Oncogene"},{"key":"BFonc2011578_CR50","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ccr.2007.12.008","volume":"13","author":"SL Yu","year":"2008","unstructured":"Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S et al. (2008). MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 13: 48\u201357.","journal-title":"Cancer Cell"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2011578.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2011578","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2011578.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T18:07:19Z","timestamp":1647886039000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2011578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,16]]},"references-count":50,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2012,9,20]]}},"alternative-id":["BFonc2011578"],"URL":"https:\/\/doi.org\/10.1038\/onc.2011.578","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,16]]},"assertion":[{"value":"29 March 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}